已收录 268921 条政策
 政策提纲
  • 暂无提纲
Dose optimisation of intravenous tranexamic acid for elective hip and knee arthroplasty
[摘要] Objectives We have increased the dose of tranexamic acid (TXA) in our enhanced total joint recovery protocol at our institution from 15 mg/kg to 30 mg/kg (maximum 2.5 g) as a single, intravenous (IV) dose. We report the clinical effect of this dosage chan
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 骨科学
[关键词] Tranexamic acid;Hip;Knee;Enhanced recovery;Arthroplasty [时效性] 
   浏览次数:28      统一登录查看全文      激活码登录查看全文